Registry studying a drug-coated balloon for coronary artery disease
Part of Heart & circulation clinical trials.
This trial is tracking the long-term safety and effectiveness of a sirolimus-eluting balloon (Selution SLR) in people with coronary artery disease. It aims to see how well this device works when used to open blocked arteries in real-world medical practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have coronary artery disease and a doctor decides the Selution SLR balloon is appropriate for you
- You have been told about the trial and signed a consent form
- You are not expected to live less than 12 months
- You have not refused to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special balloon coated with a drug (sirolimus) to treat blockages in small heart arteries. If the balloon is successful, it may help keep the artery open without needing a permanent stent.
This trial tests whether a special drug-coated balloon (“MagicTouch”) can treat re-narrowing inside a previously placed stent. It may help patients whose stent has become blocked again, by improving blood flow and reducing repeat narrowing.
This study follows adults with blocked heart arteries who are treated using a special type of balloon (drug-coated balloon) during a procedure. It aims to track real-world outcomes to better understand how well this treatment works for people with new blockages or previously treated vessel narrowing.
This study is testing a special balloon that releases a drug (sirolimus) to treat fatty plaques in heart arteries that are not yet blocking blood flow. The hope is that this treatment can stabilize or even shrink these plaques, reducing future risk of heart attacks. If you have recently had a heart attack and have other non-obstructive plaques, this trial might offer a new approach.
This study tests a drug-coated balloon (DCB) that releases two medicines (sirolimus and paclitaxel) to open blocked small heart arteries. It may help people with stable chest pain or recent, controlled heart events who have a narrowed small vessel.
This study tests a special balloon coated with a drug called sirolimus to open blocked heart arteries. It may be an option for people with coronary artery disease who need a less invasive treatment.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.